AFPW **NEWS** Portable Balloon Inflation System Show Case
AlumiFuel Power to Showcase Its Portable Balloon Inflation System at American Meteorological Society Annual Meeting
API’s Unique Technology to Be Viewed by Many Prospective Customers
PHILADELPHIA, PA–(Marketwire -12/08/11)- Early production stage hydrogen generation company AlumiFuel Power, Inc. (“API”), the Philadelphia, Pennsylvania-based wholly owned operating subsidiary of AlumiFuel Power Corporation (OTC.BB: AFPW.OB – News) (the “Company”), announced today it will display its PBIS-1000 unit at the 92nd annual American Meteorological Society (AMS) Meeting in New Orleans, January 23-26, 2012.
The annual AMS Meeting is the largest and most important weather-related conference in the U.S. It brings together all of the key players in the meteorological field, including systems integrators, instrumentation and sensor manufacturers, environmental engineering firms, weather information research and analysis organizations, government users, and commercial customers. There are over 100 exhibitors, and attendance is expected to match last year’s event, with more than 3,600 attendees from around the world.
API’s PBIS-1000, developed for a military user, with initial delivery in 2010, represents the fourth generation of PBIS technology under development since 2008. The PBIS-1000 uses 2 AlumiFuel cartridges to generate 1,000 liters of hydrogen lift gas in 20 minutes to launch a 100g weather balloon. As API’s first PBIS commercial product, the PBIS-1000 represents a unique integration of mechanical, chemical, fluid, gas, and air design leak-proof components — including coded stainless steel pressure vessels, pumps, tubing, connectors, seals, filters and gauges, all housed in a ruggedized polypropylene case. In September, 2011, API received a contract from U.S. Air Force Special Operations Command for a new system, the PBIS-2000. This new system, now under final development for a late February 2012 delivery, generates sufficient hydrogen to inflate and launch a larger 200g weather balloon.
CAD drawings of the PBIS-2000 will be on display at the AMS Meeting, along with the PBIS-1000 unit, and API will actively be taking orders for PBIS systems from new customers at the Meeting.
The current weather balloon lift gas market is pegged at $200 million per year, and encompasses military as well as civil government meteorological users worldwide. Traditionally, helium has been used as the primary lift gas for weather balloons, but with the increasing scarcity and cost of helium, users are rapidly switching to hydrogen and API’s PBIS family is far more mobile, safe, and cost effective than other on-site hydrogen generation systems. Based on customer feedback, API believes the PBIS family can become field standard and lift gas product of choice for NATO military users and meteorological customers worldwide. After purchasing any unit of the PBIS family, typical customers continue to purchase replacement cartridges to launch up to 700 balloons per unit each year (up to 4,200 cartridges).
API’s Director of Engineering, Mr. Sean McIntosh, said, “We are very enthusiastic about showcasing our world-class PBIS technology and products at the AMS Meeting, which will be attended by our present customers and many prospective new ones. The theme of this year’s Meeting, ‘Technology in Research and Operations,’ fits us perfectly.”

About AlumiFuel Power, Inc.
API (www.alumifuelpowerinc.com), the Philadelphia, Pennsylvania-based wholly owned operating subsidiary of AlumiFuel Power Corporation, is an early production stage alternative energy company that generates hydrogen gas and steam/heat through the chemical reaction of aluminum, water, and proprietary additives. This technology is ideally suited for multiple applications requiring on-site, on-demand fuel sources, serving National Security and commercial customers. API’s hydrogen feeds fuel cells for portable and back-up power; fills inflatable devices such as weather balloons; can replace costly, hard-to-handle and high pressure K-Cylinders; and provides fuel for flameless heater applications. Its hydrogen/heat output is also being designed an d developed to drive fuel cell-based and turbine-based undersea propulsion systems and auxiliary power systems. API has significant differentiators in performance, adaptability, safety and cost-effectiveness in its target market applications, with no external power required and no toxic chemicals or by-products.
About AlumiFuel Power Corporation
AlumiFuel Power Corporation operates through its wholly owned operating subsidiary, AlumiFuel Power, Inc., a Philadelphia-based early production stage alternative energy company that generates hydrogen gas and heat for multiple applications requiring on-site, on-demand fuel sources.

Safe Harbor for Forward-looking Statements
This news release may contain forward-looking statements that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, they are based on management’s current beliefs and assumptions as to future events. However, since the company’s operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated or implied. For a more complete discussion of such risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.
CONTACTS:
Investor Relations:
AlumiFuel Power, Inc.
Thomas B. Olson
Corporate Secretary
303-796-8940
Technical Information & Marketing:
API Laboratories
484-466-2427
Read The Whole Story Here:
http://investorshub.advfn.com/
Link to News:
http://finance.yahoo.com/news/
Please Read Our Disclaimer
http://www.bullquake.com/about/disclaimer/
**AFPW Market Update** 280% in Gains
Good Evening Traders,
What a fantastic week for our penny players, are current pick has been performing explosively. Yielding gains today alone in excess of 200% that means within the last two trading days AFPW has risen an astonishing 280%!!
Our Most Recent Pick$:
AFPW- 280% in Gains
AUIC- 150% in Gains
AlumiFuel Power Corp Recent Updates:
AlumiFuel Power, Inc. Provides Rationale for Why the PBIS-2000 Portable Balloon Inflation System Technology Can Become the Worldwide Lift Gas Standard
http://finance.yahoo.com/news/AlumiFuel-Power-Inc-Provides-iw-708645982.html?x=0
AlumiFuel Power, Inc. Receives U.S. Air Force Contract for PBIS-2000 Portable Balloon Inflation System
http://finance.yahoo.com/news/AlumiFuel-Power-Inc-Receives-iw-2382466376.html?x=0
**AFPW Breaking News** Dan Valladao CEO of GreenCell, Inc Speaks on Company’s Direction
Dan Valladao CEO of GreenCell, Inc Speaks on Company’s Direction
GreenCell, Inc (OTCBB: GCLL) CEO Dan Valladao spoke with SmallCapVoice.com on the current position and goals for the remainder of 2011 and beyond. To listen to this interview, please visit http://finance.yahoo.com/news/A-New-Audio-Interview-With-prnews-2623614783.html?x=0&.v=1.
Mr. Valladao is optimistic with the opportunities for GreenCell, their revolutionary product fits into many different categories that open up revenue streams into dozens of industries. Their current product, which is anticipated to be brought to by the end of this year, can be used in a variety of applications in an estimated $600 million market. This ranges from products like barbeques and home appliances to a variety of industrial applications.
The automotive market which Mr. Valladao has over 30 years experience in, could be the next big opportunity for GreenCell. GreenCell’s proprietary product can be adapted to oxygen sensors used in automobiles; this could be a major revenue stream for GreenCell to have its high quality product into one of the biggest industries in the US.
Other active stocks are Portage Resources (PINKSHEETS: POTG) Next 1 Interactive (OTCBB: NXOI) and AlumiFuel Power Corp (OTCBB: AFPW)
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Contact:
Eric Jensen
516.942.4910
http://ih.advfn.com/p.php?pid=nmona&article=49460073&symbol=AFPW
BullQuake- Jan 31th-Feb 5th Week in Review

Good Evening BullQuakers,
What a fantastic week. Members who followed our alerts undoubtedly had the opportunity to make a killing! CCME was a massive short play called earlier this week, along with OREX which exploded upwards of 50% once it found its bottom.
Big Board Trading Alerts:
$MRK (Merck & Co., Inc) climbed up 60 cents from our alert.
$CVS (Caremark Corporation) scalped for 40 cents after our alert Thursday morning.
$CCME (Chinese Media Express Holdings) was a huge short play for our members alerted feb 1st on feb 3 ccme crashed below 11 per share from over 16 per share.
$ENR (Energizer Holdings, Inc.) Plus $7.00 from our morning alert!! 2,000 shares would have yielded you $14,000 Tuesday morning!
$PLL (Pall Corporation) was a dud trading practically sideways all week.
$TNA (Direxion Daily Small Cp Bull 3x EFT) rose more than 5 points from our alert.
$VXX (iPath S&P 500 VIX Short-Term Futures ETN) was good for a quick 0.50 scalp after our alert.
$MWW (Monster Worldwide, Inc.) climbed up just shy of a point from our Monday morning alert.
Small Cap Trading Ideas:
$NPSP (NPS Pharmaceuticals, Inc) made a decent short trade this week dropping almost 20%.
$OREX (Orexigen Therapeutics, Inc) was a massive long play this week rising up more than 50% to over 3.50 per share!
$MXMI (Max Media Group Inc) hit 0.039 from out alert at 0.008 last week! That’s over a 300% in Pure Profits!
Please remember to do your due diligence. To view our full disclaimer please click here
BullQuake- CWRN 360 % EXOU 290 % TEMN 214 %

Big Board Plays
APOL (Apollo Group Inc.)- APOL was alerted at 34.50 mid week, shortly after APOL surged hitting over $40 per share.
Monster Penny Picks
CWRN (Cotton & Western Mining, Inc.) CWRN was our Play for the week! This company was alerted to our members at only 0.006, then within just a blink of an eye she Sky Rocketed over 0.02 per share! That’s Possible Gains for You of Over 360 % in just a few short days!
EXOU (Exousia Advanced Materials, Inc) EXOU Exploded up Over 290 % from our Friday Morning Alert.
TEMN (Team Nations Holdings Group) printed 0.0022 early this week after our initial alert at 0.0007! Giving Gains of 214 % plus!
BOPH (Bohai Pharmaceuticals Group, Inc.) BOPH continues its ascent from the high dollar range finishing up the week at over $2.20 per share.
Please remember to do your due diligence. To view our full disclaimer please click here
What an EXPLOSIVE week for our portfolio!

What an EXPLOSIVE week for our portfolio! Several stocks alerted on our watch list made Massive Profits!
Big Board Plays
BBY (Best Buy Co. Inc) - We alerted our members intraday of a possible bounce play around 35.15, shortly after BBY surged over $36 per share!
Monster Penny Picks
CPOW (Clean Power Concepts) – Ran up over 80% on Friday from our alert Wednesday Morning!!
FRXP (Greenworld Dev) – Was our penny loser for the week with possible gains of only 10%.. But hey profit is profit!!
IDEH (Intl Dev & Enviro Hldg) – After alerting our members Monday morning IDEH pushed hard, giving our members the opportunity to lock in 50% gains or Higher!!
For the Absolute best stock alerts and leading edge in today’s market stay tuned intraday to our twitter at @BullQuake.com
Don’t have a twitter account? Sign up today at www.twitter.com
Never Miss Another Alert, Get Twitter on your Mobile Phone Today 100% Free!
For Android – http://download.cnet.com/Twitter-for-Android-official/3000-2150_4-11379115.html
For BlackBerry- http://appworld.blackberry.com/webstore/content/8160
For iPhone – http://download.cnet.com/Twitter/3000-12941_4-75108095.html?tag=mncol;2
Please remember to do your due diligence. To view our full disclaimer please click here
Bullquake is Back in Action! More Exclusive Offers & Extremely Profitable Stock Alerts Headed Your Way!
Hello Everyone!
Bullquake is Back in Action! We are constantly searching the market for the next Major Mover so you don’t have too!
Each day we will alert you to the top premarket watch lists via twitter, the next move is up too you.
We release the biggest movers each and every week. As a bonus our subscribers will have access to weekly recaps and exclusive offers.
See why thousands of investors come to Bullquake for the leading edge! Don’t miss out on another alert! http://twitter.com/bullquake/
This Past Week’s Biggest Gainers -
CELG- Alerted at $54.50, ran to over $57.50
HBRM- Alerted at $0.005 ran to over $0.008 with more than 6 Million in Volume
YOKU- Alerted on IPO in the mid 20’s, two days later YOKU reached a high of $50 per share
MCP- Alerted as a possible Short Sell above $33, members had the opportunity to cover below $31
Now ask yourself, are you ready to profit?
Please remember to do your due diligence. To view our full disclaimer please click here
HIDE at First Glimpse- An Early Penny Pick Alert

HIDE at First Glimpse
Early Penny Pick Alert (Pk)
HIDE was brought to our attention from the increasing activity that we noticed over the past few weeks. After doing our DD and looking over the chart we feel positive that HIDE could make a major move to the upside very soon. We highly suggest that everyone do their research on this hidden gem and keep a very close eye on it in the mean time.
With over 100 years of combined telecom experience, Nucentcom Inc has established undisputable trust and long lasting relationships with numerous corporations across the globe. To meet the demands of a constantly changing global market, Nucentcom Inc’s world class customer service representatives are multilingual and operate 24/7.
About HIDE (Nucentcom Inc)
Nucentcom, Inc. is a state-of-the-art, facilities-based telecommunications and technology company specializing in providing retail, wholesale (carrier’s carrier) and other telecommunications services to carriers and subscribers in North America, Europe and Asia through the innovative use of proven technologies. Our proprietary call-processing methodology and innovative technology enable the deployment of a variety of revenue-generating services. To date the company has focused on three areas of telecommunications:
Retail Telecommunication Services – In addition to Broadband dial tone and dial around retail products, Nucentcom is creating a private VoIP network for its UPASS-Enabled Homepage with E-Commerce subscribers, whereby individuals in different countries will be able to make high quality calls to each other, for one low, monthly fixed cost.
Wholesale Carrier Solutions – Nucentcom offers wholesale services through our worldwide network to carriers, telephony resellers and others around the world by operating through various Interconnection Agreements with Telecommunication Authorities in India, Pakistan, the Middle East and Latin America.
Municipal NuMAX Networks – Nucentcom has developed a system to work with municipalities to construct a wireless network that would allow broadband internet access and other ancillary services throughout the municipality.
Nucentcom Inc Leading Platforms Support the Following Applications:
• Prepaid and Post Paid Long Distance Calling Services including traditional card-based, ANY-authenticated, and real-time rated “Bucket-of-Minutes” implementations for integration with your existing Class 5 Broadband Telephony Services
• Highly Scalable Reservation-less Audio Conferencing Services
• Voice Mail and Unified Messaging
• Full featured Class 5 Residential and Business Broadband Telephony
• Web based applications and services
Our platform provides the carrier-grade scalability and high availability needed for network-hosted Services connected to SIP or H323 enabled PSTN-to-IP Media Gateways or Session Border Controllers. This full featured SDP environment – Solaris/Linux based – includes a standards-based Application Server, Media Server, and a graphically customizable portal.
Link to HIDE’s Chart
Please remember to do your due diligence. To view our full disclaimer please click here
BullQuake- ZIPZ, LVCA, & AEZS Afternoon Recap

We first alerted ZIPZ to our members at 0.0005 yesterday afternoon. Since our alert ZIPZ has Bullishly Roared up Over 100%, testing 0.0013 for the HOD.
LVCA- We alerted this one premarket, during mid afternoon LVCA had already made our members over 12%.
AEZS- We alerted our members on Twitter mid at 1.57 about the potential for a rebound, since then AEZS has climbed to a high of 1.77! We firmly believe AEZS could start a bullish uptrend headed into the ASCO, which is scheduled for early June.
Please remember to do your due diligence. To view our full disclaimer please click here
Breaking News: (AEZS) Aeterna Zentaris: Data on Lead Anticancer Compounds Perifosine and AEZS-108 to be Presented at Upcoming ASCO Annual Meeting

QUÉBEC CITY, May 21 /PRNewswire-FirstCall/ – Aeterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), (the “Company”) a late-stage drug development company specialized in oncology and endocrine therapy, today announced that data on two of its lead anticancer compounds, perifosine and AEZS-108, will be presented at the upcoming Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4 through 8, 2010 at McCormick Place in Chicago. Two posters on perifosine, Aeterna Zentaris’ novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, will be presented in pediatric solid tumors and colorectal cancer. A poster will also be presented on the Company’s doxorubicin targeted conjugate compound, AEZS-108, in ovarian cancer.
Abstracts selected for presentation are as follows:
Perifosine
----------
Abstract # 9540: "Phase I Study of Single Agent Perifosine for
Recurrent Pediatric Solid Tumors"
Lead Author: Oren J. Becher, MD, Memorial Sloan-Kettering Cancer
Center
Presenter: Mark Kieran, MD, PhD, Dana-Farber Cancer Institute
Date and Time: Sunday, June 6, 2010, 2 pm-6 pm (poster discussion
5:40pm-6pm)
Poster Board #: 42b
Location: S Hall A2 (poster discussion in S504)
Abstract # 3531: "Final results of a randomized Phase II study of
perifosine in combination with capecitabine (P-CAP)
vs. placebo plus capecitabine (CAP) in patients (pts)
with second or third line metastatic colorectal
cancer (mCRC)"
Lead Author: Donald A. Richards, MD, PhD, Texas Oncology
Presenter: Wells Messersmith, MD, University of Colorado
Date and Time: Tuesday, June 8, 2010, 8 am-12 noon (poster
discussion 11:45 am-12 noon)
Poster Board #: 22
Location: S403 (poster discussion in S406)
AEZS-108
--------
Abstract # 5035: "Phase 2 study of AEZS-108, a targeted cytotoxic LHRH
analog, in patients with LHRH receptor positive
platinum resistant ovarian cancer"
Lead Author: Prof. Günter Emons, Chairman, Department of
Obstetrics & Gynaecology Georg-August University
Gottingen, Germany
Presenter: Prof. Günter Emons
Date and Time: Saturday, June 5, 2010 2pm- 6pm
Poster Board #: 45B
Location: S Hall A2
Copies of these abstracts are currently available and can be viewed on-line through the ASCO website: www.asco.org.
About Perifosine
Perifosine, a novel, potentially first-in-class, oral Akt inhibitor, is currently in Phase 3 trials for multiple myeloma and advanced colorectal cancer, under Special Protocol Assessment and Fast Track designation granted by the Food and Drug Administration (FDA) for both indications. FDA has also granted perifosine orphan-drug status for multiple myeloma. Furthermore, the European Medicines Agency (EMA) has issued a positive Scientific Advice as well as a positive opinion for Orphan Medicinal Product designation for perifosine for multiple myeloma.
Perifosine is also in a Phase 1 trial in pediatric patients, as well as in other Phase 1 and Phase 2 trials for several other tumor types.
Keryx Biopharmaceuticals, Inc. (Keryx) (Nasdaq:KERX – News) is Aeterna Zentaris’ partner and licensee for perifosine in the United States, Canada and Mexico. Perifosine is also out-licensed to Handok for South Korea, while Aeterna Zentaris retains rights for the rest of the world.
About AEZS-108
AEZS-108, a doxorubicin LHRH receptor targeted conjugate, is currently in a Phase 2 trial in advanced ovarian and endometrial cancer for which final results are expected before year-end. AEZS-108 has been granted orphan-drug designation by the FDA and has received a positive opinion for Orphan Medicinal Product designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for the treatment of ovarian cancer. An IND in the U.S. is in place for the treatment of bladder cancer.
About Aeterna Zentaris Inc.
Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. News releases and additional information are available at www.aezsinc.com.
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company’s actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company’s quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.
http://finance.yahoo.com/news/Aeterna-Zentaris-Data-on-Lead-prnews-473193775.html?x=0&.v=3
Please remember to do your due diligence. To view our full disclaimer please click here





